These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19004863)

  • 1. Determining the cost of genital warts: a study from Ireland.
    Dee A; Howell F; O'Connor C; Cremin S; Hunter K
    Sex Transm Infect; 2009 Sep; 85(5):402-3. PubMed ID: 19004863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France].
    Monsonégo J; Breugelmans JG; Bouée S; Lafuma A; Bénard S; Rémy V
    Gynecol Obstet Fertil; 2007 Feb; 35(2):107-13. PubMed ID: 17270482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
    Hoy T; Singhal PK; Willey VJ; Insinga RP
    Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of treatment and QALYs lost due to genital warts: data for the economic evaluation of HPV vaccines in the United Kingdom.
    Woodhall SC; Jit M; Cai C; Ramsey T; Zia S; Crouch S; Birks Y; Newton R; Edmunds WJ; Lacey CJ
    Sex Transm Dis; 2009 Aug; 36(8):515-21. PubMed ID: 19543143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
    Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
    PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients.
    Dahlstrom KR; Fu S; Chan W; Shelal Z; Ramondetta LM; Lairson DR
    Pharmacoeconomics; 2018 Nov; 36(11):1355-1365. PubMed ID: 30019118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the impact of genital warts on health-related quality of life.
    Woodhall S; Ramsey T; Cai C; Crouch S; Jit M; Birks Y; Edmunds WJ; Newton R; Lacey CJ
    Sex Transm Infect; 2008 Jun; 84(3):161-6. PubMed ID: 18339658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J; Perkins N
    N Z Med J; 2011 Jul; 124(1339):51-8. PubMed ID: 21952330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and cost of treatment of genital warts in Spain.
    Castellsagué X; Cohet C; Puig-Tintoré LM; Acebes LO; Salinas J; San Martin M; Breitscheidel L; Rémy V
    Eur J Public Health; 2009 Jan; 19(1):106-10. PubMed ID: 19112075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genital warts and HPV vaccination].
    Pilka R; Dvorák V; Fait T
    Ceska Gynekol; 2011 Dec; 76(6):468-70. PubMed ID: 22312844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The costs of treating external genital warts in England and Wales: a treatment pattern analysis.
    Langley PC; White DJ; Drake SM
    Int J STD AIDS; 2004 Aug; 15(8):501-8. PubMed ID: 15307958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
    Thomas TL
    Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and costs associated with genital warts in Canada.
    Marra F; Ogilvie G; Colley L; Kliewer E; Marra CA
    Sex Transm Infect; 2009 Apr; 85(2):111-5. PubMed ID: 18981170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of life of patients with condyloma].
    Mortensen GL; Larsen HK
    Ugeskr Laeger; 2008 Nov; 170(47):3858-62. PubMed ID: 19014739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study.
    Hillemanns P; Breugelmans JG; Gieseking F; Bénard S; Lamure E; Littlewood KJ; Petry KU
    BMC Infect Dis; 2008 Jun; 8():76. PubMed ID: 18518976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-benefit analysis on the HPV vaccine in Medicaid-enrolled females of the Appalachian region of Kentucky.
    Prasad SR; Hill R
    J Ky Med Assoc; 2008 Jun; 106(6):271-6. PubMed ID: 18630037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
    Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
    J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The health and economic burden of genital warts in a set of private health plans in the United States.
    Insinga RP; Dasbach EJ; Myers ER
    Clin Infect Dis; 2003 Jun; 36(11):1397-403. PubMed ID: 12766834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.